FDA Approved: VASOPRESSIN IN 0.9% SODIUM CHLORIDE — Original Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA granted approval for Baxter’s vasopressin in 0.9% sodium chloride under an Original Application (NDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock
• Vasodilatory Shock

Drugs mentioned

• VASOPRESSIN IN 0.9% SODIUM CHLORIDE (vasopressin)

Snippet

ORIG AP for VASOPRESSIN IN 0.9% SODIUM CHLORIDE (VASOPRESSIN IN 0.9% SODIUM CHLORIDE)